Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.
A Feb. 18 decision by the Utah Supreme Court means that more than 1,000 patients are free to pursue claims against Salt Lake City cardiologist Sherman Sorensen, who’s been accused of performing hundreds of unnecessary PFO and ASD closures.
Researchers on the EXCEL trial have been accused of withholding key mortality data when they first published results suggesting stents were as safe as open-heart surgery in treating patients with left main disease.
A review published in Circulation: Cardiovascular Interventions Jan. 24 suggests adjunctive coronary atherectomy is a clinically useful and effective tool for treating severely calcified coronary lesions—but, in reality, it’s rarely used.
Repeat revascularization isn’t a rare occurrence after PCI or CABG, according to a study of patients with left main coronary artery disease—but it can raise a person’s risk of cardiovascular death by as much as four times.
Experts at Massachusetts General Hospital have successfully performed five CV transplants using Donation after Circulatory Death donor hearts—the largest number of adult DCD heart transplants ever completed in the U.S.